Summary
Reserpine treatment resulted in altered enzyme secretion from rat pancreatic acini in response to carbamylcholine and secretin(1,2). This study was undertaken: (1) To evaluate if the alterations caused by reserpine can be prevented by EGF and/or cerulein treatments; (2) To determine the time-course of secretion recovery after reserpine treatment; and (3) To establish if EGF and/or cerulein treatments can accelerate such a recovery after the reserpine treatment. Male Sprague-Dawley rats (250-265 g) were used in these experiments. In experiment I, rats divided into three groups received either reserpine (R) or the reserpine vehicle for the controls (C) and the pair-fed controls (PF) for 7 d. During treatment, PF and R rats were given SC, twice a day, saline, EGF (10 μg/kg), cerulein (1 μg/kg), or both at the same dose. C rats received saline in gelatin. In experiment II, rats were treated for 7 d with reserpine or the vehicle as described in experiment I, were allowed a 30-d recovery period and then were killed. In experiment III, C, PF, and R rats were treated for 7 d as described in experiment I; on the 8th d and for the next 6 d, reserpine rats received saline (reserpine-saline), cerulein, EGF, or both cerulein + EGF at the same dose as indicated in experiment I. C and PF rats received saline in gelatin. After sacrifice, acini were prepared, and amylase dose-response curves to carbamylcholine (Cch) and secretin were established. EGF, cerulein, or their combination given to R rats did not improve the desensitized secretory response to Cch. The secretory responses to secretin remained altered in PF and R rats even after the hormonal treatment. After 30 d of recovery, normal secretory responses to Cch and to secretin were found in the PF- and R-treated rats; this recovery was also observed as early as 6 d in PF and R rats, and it was impaired by the cerulein treatment. In conclusion, under the present regimen, EGF did not have any major impact on the recovery process or prevention of the alterations caused by malnutrition and reserpine. Cerulein was the most potent factor capable of promoting recovery or preventing alterations of total pancreatic amylase concentration in the reserpinized rat model; however, it failed to prevent desensitization of amylase release to Cch or decreases of acinar cells’ response to secretin. Finally, the CCK analog prevented recovery of the secretory responses to Cch and secretin observed in the absence of any treatment.
Similar content being viewed by others
References
Benrezzak O, Bérubé FL, Morisset J. Alterations of amylasesecretion in the chronically reserpinized rat: an acetylcholinemediated phenomenon.Pancreas 1991; 6: 679–687.
Benrezzak O, Bérubé FL, St-Jean L, Morisset J. Alterationsof the pancreatic secretory responses to secretin and to theionophore A23187 by reserpine: a calcium mediatedphenomenon?Digestion 55: 78–85, 1994.
Martinez JR, Martinez AM, Garrett L. Chronically reserpinized rat as a model for cystic fibrosis: Na+ transportinhibitory effect in submaxillary saliva.Pediatr Res 1979; 13: 1156–1159.
McCurdy RE, Martinez JR. The chronically reserpinizedrat as a model for cystic fibrosis: alterations in pancreaticenzyme secretion and storage.Pediatr Res 1981; 15: 1308–1313.
Larose L, Poirier GG, Dumont Y, Fregeau C, Blanchard L, Morisset J. Modulation of rat pancreatic amylase secretionand muscarinic receptor populations by chronic bethanechol treatment.Eur J Pharmacol 1983; 95: 215–223.
Asselin J, Larose L, Morisset J. Short-term cholinergicdesensitization of rat pancreatic secretory response.Am JPhysiol 1987; 252: G392-G397.
Paton WDM, Vizi ES. The inhibitory action of nor-adrenaline and adrenaline on acetylcholine output by guineapig ileum longitudinal muscle strip.Br J Pharmacol 1969; 35: 10–28.
Solomon TE, Vanier M, Morisset. Cell site and time courseof DNA synthesis in pancreas after caerulein and secretin.Am J Physiol 1983; 245: G99-G105.
Solomon TE, Petersen H, Elashoff J, Grossman MI. Interaction of caerulein and secretin on the pancreatic sizeand composition in rat.Am J Physiol 1978; 235: E714-E719.
Jurkowska G, Grondin G, Massé S, Morisset J. Soybeantrypsin inhibitor and caerulein accelerate recovery ofcaerulein-induced pancreatitis in rats.Gastroenterology1992; 102: 550–562.
Bérubé FL, Benrezzak O, Vanier M, Morisset J. Effects ofcaerulein and EGF on pancreatic growth in the reserpinizedrat model.J Pediatric Gastroenterol Nutr 1993; 17: 39–48.
Dembinski A, Gregory H, Konturek SJ, Polanski M. Trophicaction of epidermal growth factor on the pancreas andgastroduodenal mucosa in rat. J Physiol 1982; 325: 35–42.
Hazlett D, Korc M, Brannon PM. Effects of malnutritionand chronic reserpine treatment on pancreatic exocrinefunction.Pediatr Res 1986; 20: 1236–1239.
Hazlett D, Brannon PM: Effects of reserpine treatment ondietary adaptation of rat exocrine pancreas.Pediatr Res 1988; 23: 176–180.
Johnson LR, Guthrie PD. Stimulation of rat oxyntic glandmucosal growth by epidermal growth factor.Am J Physiol 1980; 238: G45-G49.
Peikin SR, Rothman AJ, Batzri S, Gardner JD. Kinetics ofamylase release by dispersed acini from guinea pig pancreas.Am J Physiol 1978; 235: E743-E749.
Larose L, Dumont Y, Asselin J, Morisset J, Poirier GG. Muscarinic receptor of rat pancreatic acini:3H-QNBbinding and amylase secretion.Eur J Pharmacol 1981; 76:247–254.
Ceska M, Birath K, Brown B. A new rapid method for theclinical determination of alpha amylase activities in humanserum and urine, optimal conditions.Clin Chim Acta 1969; 26: 437–444.
Gardner JD, Costenbaker CL, Uhlemann ER. Effect ofextracellular calcium on amylase release from dispersedpancreatic acini.Am J Physiol 1979; 236: E754-E762.
Adams CJ, Storrie B. A simple DNA-dependent fluorescence enhancement assay for cell number.J HistochemCytochem 1981; 29: 326–328.
Larose L, Leclerc L, Asselin J, Ruel S, Morisset J. Muscarinic cholinergic induced secretin subsensitivity in ratisolated pancreatic acini. Effects on amylase release, cyclicadenosine monophosphate and inositol phosphate formation.Pancreas 1989; 4: 71–78.
Jaworek J, Konturek SJ, Bielanski W, Bilski J, Hladij M. Release and binding of epidermal growth factor in thepancreas of rats.Int J Pancreatol 1992; 11: 9–18.
Logsdon SD, Williams J A. Epidermal growth factor bindingand biological effects on mouse pancreatic acini.Gastroenterology 1983; 85: 339–345.
Morisset J, Larose L, Korc M. Epidermal growth factorinhibits rat pancreatic cell proliferation causes acinar cellhypertrophy, and prevents caerulein-induced desensitizationof amylase release.Endocrinology 1989; 124: 2693–2698.
Morisset J, Paquette B, Benrezzak O. The ability ofstaurosporine to modulate pancreatic acinar cell desensitizationby TPA, carbamylcholine and caerulein.CellularSignalling 1991; 3: 119–126.
Pröfrock A, Piiper A, Eckhardt L, Schulz I. Epidermalgrowth factor inhibits both cholecystokinin octapeptideinduced inositol 1.4.5 trisphosphate production and [Ca2+]increase in rat pancreatic acinar cells.Biochim Biophys ResCommun 1991; 180: 900–906.
Katsushima S, Adachi H, Honda T, Sato S, Kusui T, Onishi S, Aoki E, Noguchi M, Konishi J. Cholecystokinin down-regulates receptors for vasoactive intestinal peptide andsecretin in rat pancreatic acini.Am J Physiol 1990; 258: G395-G403.
Casteels R, Login IS. Reserpine has a direct action as acalcium antagonist on mammalian smooth muscle cells.JPhysiol 1983; 340: 403–414.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morisset, J., Béruhé, FL., Vanier, M. et al. Alterations of pancreatic amylase secretion in the reserpinized rat model of cystic fibrosis. Int J Pancreatol 16, 37–44 (1994). https://doi.org/10.1007/BF02925608
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02925608